Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

Your search for ‘Fulbright & Jaworski’ returned 1,029 results

Use advanced search filters to refine your search

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    Pharma In Brief - Data Protected: "Innovative Drug" Status Prevents Generic NOC

    Sanofi-Aventis (Sanofi) markets and sells oxaliplatin, used for the treatment of life-threatening colorectal cancer, in Canada under the brand name ELOXATIN® for use in the treatment of colorectal cancer.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    Pharma In Brief - Federal Court Of Appeal Affirms Rejection Of Heightened Sound Prediction Patent Disclosure Requirements

    Allergan obtained a prohibition order against Apotex under section 6 of the PMNOC Regulations with respect to the drug bimatoprost and Canadian Patent No. 2,585,691
    CanadaFood, Drugs, Healthcare, Life Sciences
Norton Rose Fulbright Canada LLP
Norton Rose Fulbright Canada LLP
  • Article

    Pharma In Brief - Federal Court Stays NOC Issuance Pending Judicial Review Of New Drug's Entitlement To Data Protection

    Horizon Pharma PLC is seeking approval to market the drug RAVICTI (glycerol phenylbutyrate) for the treatment of urea cycle disorders.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    Pharma In Brief - Life Sciences Companies And Canada’s New Law Governing Electronic Communications

    Many of the provisions of Canada’s law governing commercial electronic messages (CEMs) will come into effect on July 1, 2014.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    Government Of Canada Amends Integrity Regime: Less Debarment, But More Suspension

    The federal government's procurement department, Public Works and Government Services Canada (PWGSC), recently amended its integrity regime for bidders and contractors seeking to enter into contracts with the federal government.
    CanadaGovernment, Public Sector
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    Quebec Court Of Appeal: The Insurer Does Not Always Have To Pay All Defence Costs

    Under Article 2503 of the Civil Code of Québec, a liability insurer is bound to assume the defence costs resulting from actions that are taken against its insured and covered by the insured’s insurance policy.
    CanadaInsurance
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    Cette demande de brevet sera-t-elle un complément, une continuation ou une continuation-en-partie? Partie 1 – la demande de brevet complémentaire

    Ce billet, ainsi que les deux qui le suivront, exploreront les différences et les nuances entre trois types de demandes de brevet disponibles aux États-Unis.
    CanadaIntellectual Property
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    IP Monitor - A Controversial Diagnosis: New Patent Examination Guidance In Canada For Evaluating Diagnostic Methods

    On June 29, 2015, the Canadian Intellectual Property Office issued guidance to patent examiners on examining patent applications for medical diagnostic methods.
    CanadaIntellectual Property
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    IP Monitor - No Copyright And Trade-Mark Rights In Most Metatags

    This case is the most recent in a small line of cases concerning the intellectual property implications, or lack thereof, in using website metatags formulated based on a competitor's website or trade-marks.
    CanadaIntellectual Property
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    Pharma In Brief - Federal Court Dismisses Application For Order Prohibiting Mylan From Receiving NOC For Cinacalcet

    The Federal Court dismissed Amgen's application for an order prohibiting the Minister of Health from issuing a Notice of Compliance (NOC).
    CanadaIntellectual Property
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    Highlights Of The February 20, 2014 Quebec Budget

    On February 20, 2014, the Quebec Minister of Finance and the Economy, Mr. Nicolas Marceau, tabled his government’s second budget, which includes only a handful of tax measures.
    CanadaTax
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    Supreme Court Of Canada Rules On Value Of Assumed Obligations In Asset Sales

    On May 23, 2013, the Supreme Court of Canada rendered its decision in "Daishowa-Marubeni International Ltd. v Canada".
    CanadaTax
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    Ontario Superior Court Sheds New Light On Advance Notice Bylaws

    The Ontario Superior Court recently offered new guidance on interpreting advance notice bylaws in the context of proxy contests for control of an issuer.
    CanadaCorporate/Commercial Law
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    Ontario’s Court Of Appeal Clarifies The Assumption Of Jurisdiction On The Basis Of Contract

    When can an Ontario contract be used to maintain proceedings against a foreign defendant in Ontario?
    CanadaLitigation, Mediation & Arbitration
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    Fuel Hauler Runs Out Of Gas As Supreme Court Of Canada Dismisses Its Appeal That Joint Purchase Agreement Is Anti-Competitive

    The Supreme Court of Canada recently ruled1 legitimate oil and gas joint ventures are not anti-competitive.
    CanadaAntitrust/Competition Law
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    Federal Government Launches Consultation On Canada Business Corporations Act

    On December 11, 2013, the Canadian minister of industry announced a public consultation on the Canada Business Corporations Act (CBCA) to identify ways the CBCA can potentially be amended to improve the corporate governance of corporations subject to its legislation (the Consultation Paper).
    CanadaCorporate/Commercial Law
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    Take-Aways From The SCC's Decision In CIBC v Green

    On December 4 the Supreme Court of Canada released its long-awaited decision in a trilogy of secondary market securities class action appeals that were argued together.
    CanadaCorporate/Commercial Law
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    Discrimination In Employment Based On Civil Status: Spouses Are Not Barred From Working In A Superior-Subordinate Relationship

    The Quebec Commission des relations du travail recently discussed the prohibition on discrimination in employment based on an employee’s civil status.
    CanadaEmployment and HR
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    Notice Of Resignation: The Supreme Court Restores The Dominant Line Of Authority

    The Supreme Court thus overturned a Quebec Court of Appeal ruling in 2013 that broke with the prevailing trend in the case law.
    CanadaEmployment and HR
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    Supreme Court Ushers In New Era Of Constitutional Protection For Labour Rights

    Canada’s highest court handed down three landmark decisions drawing connections between collective bargaining, the right to strike, and the Charter-protected rights to freedom of association and speech.
    CanadaEmployment and HR
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Showing 781–800 of 1029 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics